Stem Cells Make Bone Marrow Cancer Resistant to Treatment Scientists at the Johns Hopkins Kimmel Cancer Center provided evidence that cancer stem cells for multiple
myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatments.
Not exact matches
Within weeks of her diagnosis in 1996, Giusti began disrupting the
myeloma research culture — getting isolated doctors and scientists to
share data, and building an unheard - of consortium to develop drugs.
Shares of Ligand Pharmaceuticals shed nearly 12 percent Tuesday after Amgen said its multiple
myeloma drug, Kyprolis, did not outperform Takeda Pharmaceutical's Velcade in a late - stage study.
Shares of Ligand Pharmaceuticals plunged 12 percent Tuesday after Amgen said its multiple
myeloma drug, Kyprolis, did not outperform Takeda Pharmaceutical's Velcade in a late - stage study.
Celgene's lead product, Revlimid, a drug designed to treat multiple
myeloma and a few other cancer types, has been benefiting from longer duration of use, strong pricing power, and high multiple
myeloma market
share.
NMP
shares certain mechanistic similarities with other promising drug candidates for
myeloma that were discovered in more traditional ways.